(Q31945974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

review article

1 reference

title

Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

T C Andrews

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

Trends in Molecular Medicine

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

532-539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Evidence for specific cognitive deficits in preclinical Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Differential loss of striatal projection neurons in Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Brain Function and Blood Flow / Niels A. Lassen, David H. Ingvar and Erik Skinhøj. - (10.1978)

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Positron emission tomography in the early diagnosis of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Cortical glucose metabolism in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Cortical control of movement in Huntington's disease. A PET activation study

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Central motor processing in Huntington's disease. A PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Alterations in dopaminergic receptors in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Dopamine D-1 and D-2 receptors in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas A PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Positron emission tomography measures of benzodiazepine receptors in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Cerebral blood flow and cognitive testing correlate in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Prefrontal cortical blood flow and cognitive function in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Regional cerebral blood flow and cognitive function in Huntington's disease and schizophrenia. A comparison of patients matched for performance on a prefrontal-type task

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Heterogeneous dopamine receptor changes in early and late Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Therapeutic strategies for Huntington's disease based on a molecular understanding of the disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Brain atrophy in Huntington's disease. A CT-scan study

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Computed tomography for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

Neuropsychological and neuroradiological correlates in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901371-9

7 January 2021

10.1016/S1357-4310(98)01371-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9866823%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference